Unosi

• Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption (2015-06)

  P. Suwannasom, Y. Onuma, C. Campos, S. Nakatani, Y. Ishibashi, H. Tateishi, M. Grundeken, B. Stanetić, K. Nieman, H. Jonker, H. Garcia-Garcia, P. Serruys, Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 8, No. 8, pp. 1130 - 1132, Jun, 2015

• Novel bioresorbable scaffolds technologies: current status and future directions. (2015-08)

  B. Stanetić, J. Iqbal, Y. Onuma, P. Serruys, Novel bioresorbable scaffolds technologies: current status and future directions., Minerva Cardioangiologica , Vol. 63, No. 4, pp. 297 - 315, Aug, 2015

• Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. (2015-11)

  B. Stanetić, C. Campos, V. Farooq, S. Walsh, Y. Ishibashi, Y. Onuma, H. Garcia-Garcia, J. Escaned, A. Banning, P. Serruys, Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial., CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 15, No. 86, pp. 229 - 238, Nov, 2015

• Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016-06)

  J. Escaned, A. Banning, V. Farooq, M. Echavarria-Pinto, Y. Onuma, N. Ryan, R. Calvacante, C. Campos, B. Stanetić, Y. Ishibashi, P. Suwannasom, A. Kappetein, D. Taggart, M. Morel, G. van Es, P. Serruys, Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease., EuroIntervention, Vol. 12, No. 2, pp. 224 - 234, Jun, 2016

• ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. (2017-01)

  BM. Stanetić, M. Ostojić, C. Campos, J. Marinkovic, V. Farooq, T. Kovačević-Preradović, K. Huber, P. Serruys, ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study., INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol. 227, pp. 478 - 484, Jan, 2017

• Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017-02)

  C. Collet, T. Asano, Y. Sotomi, R. Calvacante, B. Stanetić, Y. Miyazaki, Y. Zeng, K. Tummala, J. Tijssen, R. De Winter, Y. Onuma, D. Capodanno, P. Serruys, Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies., Minerva Cardioangiologica (Testo stampato), Vol. 65, No. 1, pp. 32 - 51, Feb, 2017

• Diagnosis and Treatment of Pulmonary Hypertension. (2017-06)

  T. Kovačević-Preradović, B. Stanetić, Diagnosis and Treatment of Pulmonary Hypertension., SCRIPTA MEDICA, Vol. 48, No. 1, pp. 68 - 76, Jun, 2017

• Prognostic Capability Of The Syntax Score Ii Among 414 Consecutive Patients With Complex Coronary Artery Disease Who Underwent Coronary Artery Bypass Grafting; Proust Study. (2018-05)

  B. Stanetić, M. Ostojić, T. Kovačević-Preradović, I. Tentzeris, M. Rohla, K. Huber, Prognostic Capability Of The Syntax Score Ii Among 414 Consecutive Patients With Complex Coronary Artery Disease Who Underwent Coronary Artery Bypass Grafting; Proust Study., Časopis udruženja pulmologa Republike Srpske, Vol. 8, No. 2, pp. 83 - 92, May, 2018

• One-Year Outcomes after PCI Strategies in Cardiogenic Shock (2018-09)

  B. Stanetić, One-Year Outcomes after PCI Strategies in Cardiogenic Shock, EuroIntervention, pp. -- - --, Sep, 2018

• Coronary stenosis and left ventricular function - Major prognostic factors in patients with ischemic heart disease: Has something changed in the era of "precision medicine"? (2019-03)

  M. Ostojić, B. Stanetić, T. Kovačević-Preradović, D. Boljevic, D. Vulić, Coronary stenosis and left ventricular function - Major prognostic factors in patients with ischemic heart disease: Has something changed in the era of "precision medicine"?, INTERNATIONAL JOURNAL OF CARDIOLOGY, No. 278, pp. 36 - 37, Mar, 2019

• Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. (2019-04)

  B. Stanetić, Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries., ATHEROSCLEROSIS, pp. 345 - 354, Apr, 2019

• THE ROLE OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN THE ASSESSMENT OF RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: RESULTS FROM SERBIAN UNIVERSITY PULMONARY EMBOLISM REGISTRY (SUPER). (2019-06)

  L. Kos, B. Stanetić, T. Kovačević-Preradović, M. Ostojic, THE ROLE OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN THE ASSESSMENT OF RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: RESULTS FROM SERBIAN UNIVERSITY PULMONARY EMBOLISM REGISTRY (SUPER)., Časopis udruženja pulmologa Republike Srpske, Vol. 9, No. 1-2, pp. 1 - 6, Jun, 2019

• How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucose cotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2 diabetes? (2020-02)

  T. Kovačević-Preradović, Z. Zivanović, B. Stanetić, L. Kos, N. Sobot, S. Stojkovic, D. Uncanin, How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucose cotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2 diabetes?, Srce i krvni sudovi, Vol. 39, No. 1, pp. 8 - 10, Feb, 2020

• Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery DiseasedA Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V (2020-02)

  B. Stanetić, Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery DiseasedA Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V, DIABETES CARE, Vol. 67, No. 2, pp. 15 - 25, Feb, 2020

• The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease (2021-04)

  B. Stanetić, The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease, GLOBAL HEART JOURNAL, Vol. 16, No. 1, pp. 22 - 27, Apr, 2021

• Prescribing pattern of benzodi- azepines in outpatients without a diagnosis of mental disorders - Retrospective study (2021-05)

  B. Stanetić, Prescribing pattern of benzodi- azepines in outpatients without a diagnosis of mental disorders - Retrospective study, Opšta medicina, Vol. 27, No. 2, pp. 1 - 10, May, 2021

• A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial (2021-08)

  M. Noc, P. Laanmets, A. Neskovic, M. Petrovic, B. Stanetić, D. Aradi, R. Kiss, I. Ungi, B. Merkely, M. Hudec, P. Blasko, I. Horvath, J. Davies, V. Vukcevic, M. Holzer, B. Metzler, A. Witkowski, A. Erglis, M. Fister, G. Nagy, J. Bulum, I. Edes, J. Peruga, B. Średniawa, D. Erlinge, T. Keeble, A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial, EuroIntervention, Vol. 1, No. 17, pp. 466 - 473, Aug, 2021

• Effective therapeutic strategies for diabetic cardiomyopathy (2021-06)

  T. Kovačević-Preradović, B. Stanetić, Z. Zivanovic, L. Kos, N. Sobot, S. Stojkovic, D. Uncanin, Effective therapeutic strategies for diabetic cardiomyopathy, Srce i krvni sudovi, Vol. 40, No. 1, pp. 5 - 7, Jun, 2021

• Severe mitral regurgitation in a young patient - how would you treat? (2021-06)

  B. Stanetić, T. Kovačević-Preradović, L. Kos, Z. Zivanovic, M. Ostojic, Severe mitral regurgitation in a young patient - how would you treat?, Srce i krvni sudovi, Vol. 40, No. 1, pp. 12 - 14, Jun, 2021

• Effect of using HEART score in patients with chest pain at the emergency department of University Clinical Centre of the Republic of Srpska (2021-07)

  B. Stanetić, N. Jacimovic, S. Porcic, Effect of using HEART score in patients with chest pain at the emergency department of University Clinical Centre of the Republic of Srpska, BIOMEDICINSKA ISTRAŽIVANjA, Vol. 12, No. 1, pp. 1 - 8, Jul, 2021